News and information about universal access to health care; the impact of restrictive policies and financial challenges on access to treatment; drug stock-outs; and scaling up services.

Access to medicines and treatment: latest news

Access to medicines and treatment resources

Access to medicines and treatment features

Access to medicines and treatment news from aidsmap

More news

Access to medicines and treatment news selected from other sources

  • Venezuela Falls Under The Triple Attack of HIV, Tuberculosis And Malaria

    A little over a year later, the situation is a lot more serious than we originally foresaw. Every health, poverty, nutrition, economic growth and social development index in Venezuela has loudly worsened, while the Venezuelan government keeps on denying not only the existence of the humanitarian crisis affecting the country but even worse, the entrance of humanitarian aid.

    16 April 2019 | Caracas Chronicles
  • “Dialogue” Highlighted As Way Forward At Closure Of WHO Fair Pricing Forum

    WHO said that it will launch a public online consultation involving governments, industry and civil society to try to come up with a broad consensus on what actually constitutes a “fair price” for essential medicines.

    15 April 2019 | Health Policy Watch
  • Tackling the high price of medicine

    Profit seems to be the only logic driving medicine prices, with some African countries paying more for medicine than European countries, and US citizens paying some of the highest medicine prices in the world. While there are global efforts to rein in pharmaceutical companies’ excessive profiteering from sickness, trying to remove the secrecy around prices is complicated.

    15 April 2019 | Daily Maverick
  • UK: Ministers accused of cover-up over migrant health reports

    Ministers have been accused of a cover-up for refusing to release official reports into whether migrants’ health has been harmed since they began being charged upfront for NHS care before they can be treated.

    05 April 2019 | The Guardian
  • PrEP Pricing Is the Elephant in the Room at the CDC National HIV Prevention Conference

    Pre-exposure prophylaxis (PrEP) was supposed to usher in an end to the HIV epidemic. Now, seven years after its approval, it's clear that the once-daily pill has failed to reach the very patients who need it most. For veteran HIV researcher Michael Saag, M.D., with the University of Alabama at Birmingham, the reason is simple: PrEP is too expensive.

    24 March 2019 | The Body
  • Little advice in place for patients in England if drug supplies dry up

    The Department of Health and Social Care and NHS England have given little practical advice to patients in England about what they can do if they are left unable to get hold of their normal drugs.

    24 March 2019 | The Guardian
  • Interview With Charles Gore, Medicines Patent Pool Executive Director

    Charles Gore took over the role of Executive Director at the Medicines Patent Pool in July 2018, just after its board decided to greatly expand its mandate into essential medicines. Nine months into his term, IP-Watch’s William New talked with him about his role and how the expansion is going.

    24 March 2019 | Intellectual Property Watch
  • South Africa: Shortage of drug puts thousands of Aids patients at risk

    Health authorities have confirmed the shortage of Darunavir, a third-line drug. Third-line drugs are used when patients have few drug options left to treat their condition.

    15 March 2019 | Independent Online
  • India’s first LGBTQ clinic and HIV treatment centre inaugurated in Mumbai

    Based out of the Humsafar Trust’s office jn Mumbai, the centre will give free counselling and provide Anti-Retroviral Therapy (ART) to the LGBTQ community. TAshok Row Kavi, founder chairperson of the Trust, said: “Until now we would get testing done for the community members at our centre. If tested positive for the disease, they would be asked to go to Sion Hospital, but there was a huge dropout (rate) there. Because of how the community is perceived outside, a lot of these people wouldn’t seek treatment."

    12 March 2019 | Hindustan Times
  • Big Pharma Gave Money To Patient Advocacy Groups Opposing Medicare Changes

    Dozens of patient advocacy groups, like the Bonnie J. Addario Lung Cancer Foundation and the National Coalition for Cancer Survivorship, recently appeared in national advertisements objecting to a Trump administration proposal that could limit drugs covered by Medicare providers. But a Kaiser Health News analysis found that about half of the groups representing patients have received funding from the pharmaceutical industry.

    05 March 2019 | Kaiser Health News
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.